Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects

Simian Virus 40 (SV40), a monkey polyomavirus, was administered to human populations by early anti‐poliomylitis vaccines contaminated by this small DNA tumor virus. Data on SV40 infection in humans remain controversial. Elderly subjects represent an interesting cohort to investigate, because they we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2017-01, Vol.232 (1), p.176-181
Hauptverfasser: Mazzoni, Elisa, Guerra, Giovanni, Casali, Maria Vittoria, Pietrobon, Silvia, Bononi, Ilaria, Puozzo, Andrea, Tagliapietra, Andrea, Nocini, Pier Francesco, Tognon, Mauro, Martini, Fernanda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 181
container_issue 1
container_start_page 176
container_title Journal of cellular physiology
container_volume 232
creator Mazzoni, Elisa
Guerra, Giovanni
Casali, Maria Vittoria
Pietrobon, Silvia
Bononi, Ilaria
Puozzo, Andrea
Tagliapietra, Andrea
Nocini, Pier Francesco
Tognon, Mauro
Martini, Fernanda
description Simian Virus 40 (SV40), a monkey polyomavirus, was administered to human populations by early anti‐poliomylitis vaccines contaminated by this small DNA tumor virus. Data on SV40 infection in humans remain controversial. Elderly subjects represent an interesting cohort to investigate, because they were not immunized with SV40‐contaminated vaccines. Taking advantage of the Italian population, the second oldest worldwide, elderly subjects (n = 237) up to 100 years old were enrolled in this study. Their sera were analyzed, by ELISA tests with synthetic peptides mimicking the viral epitopes, for IgG antibodies reacting with SV40 large Tumor antigen (Tag), the viral oncoprotein. An overall seroprevalence of 22% was revealed in subjects aged 66–100 years, ranging from 19% in individuals 66–74 years old, to 24% in subjects 82–100 years old, with a lower SV40 titer detected in the oldest group. Our data show that: (i) SV40 infection is not frequent in old individuals; (ii) the infection rate increases in elderly with the age; (iii) the antibody titer of SV40 Tag decreases with the age. In conclusion, SV40 infection seems to spread in old subjects independently from SV40‐contaminated vaccines. This study seems to confirm that SV40 is also a human virus. J. Cell. Physiol. 232: 176–181, 2017. © 2016 Wiley Periodicals, Inc. Specific antibodies reacting against Simian Virus 40 large T antigen mimotopes were detected in serum samples from elderly healthy subjects, up to 100 years old, with a prevalence of 22%. Immunological data were obtained with a novel indirect ELISA with synthetic peptides, which mimic the immunogenic epitopes of the viral oncoprotein of SV40. Our data suggests that the exposure to Simian Virus 40 infection is not frequent in old individuals. The immunological results showed that (i) the infection rate increases in elderly with the age; (ii) the proportion of elderly subjects with high Simian Virus 40 large T antigen antibody levels decreases with age; (iii) Simian Virus 40 infection spreads in old subjects independently from SV40‐contaminated vaccines; (iv) this monkey polyomavirus is also a viral agent in humans.
doi_str_mv 10.1002/jcp.25405
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1827920403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1827920403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4225-1bd1cbf85b5249a92ef344bd2104d44bcf4e606ccf9b1037b8b8f16d86b6e5c63</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EotvCgS-ALHHpoWnHjp3Ex9Wqf7WoSFu4RrYz2XqVxMFOhPbGR6-3LRw4cZrRm988zegR8onBOQPgFzs7nnMpQL4hCwaqzEQh-VuySDOWKSnYETmOcQcASuX5e3LESyiEZLAgv5fD5IxvHEa63Go3xIl-db2f_JgU39KN650e6A8X5kgF0LUOW6QP9LC3xeGMTo9I7wfrx-AndElwA91gmHu60f3YJZer4Ht62TUYuj29Qd1Nj3u6mc0O7RQ_kHet7iJ-fK0n5PvV5cPqJlvfX9-uluvMCs5lxkzDrGkraSQXSiuObS6EaTgD0aTGtgILKKxtlWGQl6YyVcuKpipMgdIW-Qk5ffFNd_6cMU5176LFrtMD-jnWrOKl4iAg_x-UM1aWQiX0yz_ozs9hSI8cKKhKAFkm6vMrNZsem3oMrtdhX_-JIQEXL8Av1-H-75xBfci3TvnWz_nWd6tvz03-BEJjlgY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1820870057</pqid></control><display><type>article</type><title>Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Mazzoni, Elisa ; Guerra, Giovanni ; Casali, Maria Vittoria ; Pietrobon, Silvia ; Bononi, Ilaria ; Puozzo, Andrea ; Tagliapietra, Andrea ; Nocini, Pier Francesco ; Tognon, Mauro ; Martini, Fernanda</creator><creatorcontrib>Mazzoni, Elisa ; Guerra, Giovanni ; Casali, Maria Vittoria ; Pietrobon, Silvia ; Bononi, Ilaria ; Puozzo, Andrea ; Tagliapietra, Andrea ; Nocini, Pier Francesco ; Tognon, Mauro ; Martini, Fernanda</creatorcontrib><description>Simian Virus 40 (SV40), a monkey polyomavirus, was administered to human populations by early anti‐poliomylitis vaccines contaminated by this small DNA tumor virus. Data on SV40 infection in humans remain controversial. Elderly subjects represent an interesting cohort to investigate, because they were not immunized with SV40‐contaminated vaccines. Taking advantage of the Italian population, the second oldest worldwide, elderly subjects (n = 237) up to 100 years old were enrolled in this study. Their sera were analyzed, by ELISA tests with synthetic peptides mimicking the viral epitopes, for IgG antibodies reacting with SV40 large Tumor antigen (Tag), the viral oncoprotein. An overall seroprevalence of 22% was revealed in subjects aged 66–100 years, ranging from 19% in individuals 66–74 years old, to 24% in subjects 82–100 years old, with a lower SV40 titer detected in the oldest group. Our data show that: (i) SV40 infection is not frequent in old individuals; (ii) the infection rate increases in elderly with the age; (iii) the antibody titer of SV40 Tag decreases with the age. In conclusion, SV40 infection seems to spread in old subjects independently from SV40‐contaminated vaccines. This study seems to confirm that SV40 is also a human virus. J. Cell. Physiol. 232: 176–181, 2017. © 2016 Wiley Periodicals, Inc. Specific antibodies reacting against Simian Virus 40 large T antigen mimotopes were detected in serum samples from elderly healthy subjects, up to 100 years old, with a prevalence of 22%. Immunological data were obtained with a novel indirect ELISA with synthetic peptides, which mimic the immunogenic epitopes of the viral oncoprotein of SV40. Our data suggests that the exposure to Simian Virus 40 infection is not frequent in old individuals. The immunological results showed that (i) the infection rate increases in elderly with the age; (ii) the proportion of elderly subjects with high Simian Virus 40 large T antigen antibody levels decreases with age; (iii) Simian Virus 40 infection spreads in old subjects independently from SV40‐contaminated vaccines; (iv) this monkey polyomavirus is also a viral agent in humans.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.25405</identifier><identifier>PMID: 27064510</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Aged, 80 and over ; Aging ; Antibodies - blood ; Antibodies - immunology ; Antigens, Viral, Tumor - immunology ; Female ; Healthy Volunteers ; Human populations ; Humans ; Immunization ; Male ; Oncogene Proteins - immunology ; Peptides ; Polyomaviridae ; Polyomavirus ; Polyomavirus Infections - immunology ; Polyomavirus Infections - virology ; Retroviridae ; Seroepidemiologic Studies ; Simian virus 40 ; Simian virus 40 - immunology ; Tumor Virus Infections - immunology ; Tumor Virus Infections - virology ; Vaccines</subject><ispartof>Journal of cellular physiology, 2017-01, Vol.232 (1), p.176-181</ispartof><rights>2016 Wiley Periodicals, Inc.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4225-1bd1cbf85b5249a92ef344bd2104d44bcf4e606ccf9b1037b8b8f16d86b6e5c63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.25405$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.25405$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27064510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mazzoni, Elisa</creatorcontrib><creatorcontrib>Guerra, Giovanni</creatorcontrib><creatorcontrib>Casali, Maria Vittoria</creatorcontrib><creatorcontrib>Pietrobon, Silvia</creatorcontrib><creatorcontrib>Bononi, Ilaria</creatorcontrib><creatorcontrib>Puozzo, Andrea</creatorcontrib><creatorcontrib>Tagliapietra, Andrea</creatorcontrib><creatorcontrib>Nocini, Pier Francesco</creatorcontrib><creatorcontrib>Tognon, Mauro</creatorcontrib><creatorcontrib>Martini, Fernanda</creatorcontrib><title>Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects</title><title>Journal of cellular physiology</title><addtitle>J Cell Physiol</addtitle><description>Simian Virus 40 (SV40), a monkey polyomavirus, was administered to human populations by early anti‐poliomylitis vaccines contaminated by this small DNA tumor virus. Data on SV40 infection in humans remain controversial. Elderly subjects represent an interesting cohort to investigate, because they were not immunized with SV40‐contaminated vaccines. Taking advantage of the Italian population, the second oldest worldwide, elderly subjects (n = 237) up to 100 years old were enrolled in this study. Their sera were analyzed, by ELISA tests with synthetic peptides mimicking the viral epitopes, for IgG antibodies reacting with SV40 large Tumor antigen (Tag), the viral oncoprotein. An overall seroprevalence of 22% was revealed in subjects aged 66–100 years, ranging from 19% in individuals 66–74 years old, to 24% in subjects 82–100 years old, with a lower SV40 titer detected in the oldest group. Our data show that: (i) SV40 infection is not frequent in old individuals; (ii) the infection rate increases in elderly with the age; (iii) the antibody titer of SV40 Tag decreases with the age. In conclusion, SV40 infection seems to spread in old subjects independently from SV40‐contaminated vaccines. This study seems to confirm that SV40 is also a human virus. J. Cell. Physiol. 232: 176–181, 2017. © 2016 Wiley Periodicals, Inc. Specific antibodies reacting against Simian Virus 40 large T antigen mimotopes were detected in serum samples from elderly healthy subjects, up to 100 years old, with a prevalence of 22%. Immunological data were obtained with a novel indirect ELISA with synthetic peptides, which mimic the immunogenic epitopes of the viral oncoprotein of SV40. Our data suggests that the exposure to Simian Virus 40 infection is not frequent in old individuals. The immunological results showed that (i) the infection rate increases in elderly with the age; (ii) the proportion of elderly subjects with high Simian Virus 40 large T antigen antibody levels decreases with age; (iii) Simian Virus 40 infection spreads in old subjects independently from SV40‐contaminated vaccines; (iv) this monkey polyomavirus is also a viral agent in humans.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging</subject><subject>Antibodies - blood</subject><subject>Antibodies - immunology</subject><subject>Antigens, Viral, Tumor - immunology</subject><subject>Female</subject><subject>Healthy Volunteers</subject><subject>Human populations</subject><subject>Humans</subject><subject>Immunization</subject><subject>Male</subject><subject>Oncogene Proteins - immunology</subject><subject>Peptides</subject><subject>Polyomaviridae</subject><subject>Polyomavirus</subject><subject>Polyomavirus Infections - immunology</subject><subject>Polyomavirus Infections - virology</subject><subject>Retroviridae</subject><subject>Seroepidemiologic Studies</subject><subject>Simian virus 40</subject><subject>Simian virus 40 - immunology</subject><subject>Tumor Virus Infections - immunology</subject><subject>Tumor Virus Infections - virology</subject><subject>Vaccines</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxS0EotvCgS-ALHHpoWnHjp3Ex9Wqf7WoSFu4RrYz2XqVxMFOhPbGR6-3LRw4cZrRm988zegR8onBOQPgFzs7nnMpQL4hCwaqzEQh-VuySDOWKSnYETmOcQcASuX5e3LESyiEZLAgv5fD5IxvHEa63Go3xIl-db2f_JgU39KN650e6A8X5kgF0LUOW6QP9LC3xeGMTo9I7wfrx-AndElwA91gmHu60f3YJZer4Ht62TUYuj29Qd1Nj3u6mc0O7RQ_kHet7iJ-fK0n5PvV5cPqJlvfX9-uluvMCs5lxkzDrGkraSQXSiuObS6EaTgD0aTGtgILKKxtlWGQl6YyVcuKpipMgdIW-Qk5ffFNd_6cMU5176LFrtMD-jnWrOKl4iAg_x-UM1aWQiX0yz_ozs9hSI8cKKhKAFkm6vMrNZsem3oMrtdhX_-JIQEXL8Av1-H-75xBfci3TvnWz_nWd6tvz03-BEJjlgY</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Mazzoni, Elisa</creator><creator>Guerra, Giovanni</creator><creator>Casali, Maria Vittoria</creator><creator>Pietrobon, Silvia</creator><creator>Bononi, Ilaria</creator><creator>Puozzo, Andrea</creator><creator>Tagliapietra, Andrea</creator><creator>Nocini, Pier Francesco</creator><creator>Tognon, Mauro</creator><creator>Martini, Fernanda</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>201701</creationdate><title>Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects</title><author>Mazzoni, Elisa ; Guerra, Giovanni ; Casali, Maria Vittoria ; Pietrobon, Silvia ; Bononi, Ilaria ; Puozzo, Andrea ; Tagliapietra, Andrea ; Nocini, Pier Francesco ; Tognon, Mauro ; Martini, Fernanda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4225-1bd1cbf85b5249a92ef344bd2104d44bcf4e606ccf9b1037b8b8f16d86b6e5c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging</topic><topic>Antibodies - blood</topic><topic>Antibodies - immunology</topic><topic>Antigens, Viral, Tumor - immunology</topic><topic>Female</topic><topic>Healthy Volunteers</topic><topic>Human populations</topic><topic>Humans</topic><topic>Immunization</topic><topic>Male</topic><topic>Oncogene Proteins - immunology</topic><topic>Peptides</topic><topic>Polyomaviridae</topic><topic>Polyomavirus</topic><topic>Polyomavirus Infections - immunology</topic><topic>Polyomavirus Infections - virology</topic><topic>Retroviridae</topic><topic>Seroepidemiologic Studies</topic><topic>Simian virus 40</topic><topic>Simian virus 40 - immunology</topic><topic>Tumor Virus Infections - immunology</topic><topic>Tumor Virus Infections - virology</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazzoni, Elisa</creatorcontrib><creatorcontrib>Guerra, Giovanni</creatorcontrib><creatorcontrib>Casali, Maria Vittoria</creatorcontrib><creatorcontrib>Pietrobon, Silvia</creatorcontrib><creatorcontrib>Bononi, Ilaria</creatorcontrib><creatorcontrib>Puozzo, Andrea</creatorcontrib><creatorcontrib>Tagliapietra, Andrea</creatorcontrib><creatorcontrib>Nocini, Pier Francesco</creatorcontrib><creatorcontrib>Tognon, Mauro</creatorcontrib><creatorcontrib>Martini, Fernanda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazzoni, Elisa</au><au>Guerra, Giovanni</au><au>Casali, Maria Vittoria</au><au>Pietrobon, Silvia</au><au>Bononi, Ilaria</au><au>Puozzo, Andrea</au><au>Tagliapietra, Andrea</au><au>Nocini, Pier Francesco</au><au>Tognon, Mauro</au><au>Martini, Fernanda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J Cell Physiol</addtitle><date>2017-01</date><risdate>2017</risdate><volume>232</volume><issue>1</issue><spage>176</spage><epage>181</epage><pages>176-181</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>Simian Virus 40 (SV40), a monkey polyomavirus, was administered to human populations by early anti‐poliomylitis vaccines contaminated by this small DNA tumor virus. Data on SV40 infection in humans remain controversial. Elderly subjects represent an interesting cohort to investigate, because they were not immunized with SV40‐contaminated vaccines. Taking advantage of the Italian population, the second oldest worldwide, elderly subjects (n = 237) up to 100 years old were enrolled in this study. Their sera were analyzed, by ELISA tests with synthetic peptides mimicking the viral epitopes, for IgG antibodies reacting with SV40 large Tumor antigen (Tag), the viral oncoprotein. An overall seroprevalence of 22% was revealed in subjects aged 66–100 years, ranging from 19% in individuals 66–74 years old, to 24% in subjects 82–100 years old, with a lower SV40 titer detected in the oldest group. Our data show that: (i) SV40 infection is not frequent in old individuals; (ii) the infection rate increases in elderly with the age; (iii) the antibody titer of SV40 Tag decreases with the age. In conclusion, SV40 infection seems to spread in old subjects independently from SV40‐contaminated vaccines. This study seems to confirm that SV40 is also a human virus. J. Cell. Physiol. 232: 176–181, 2017. © 2016 Wiley Periodicals, Inc. Specific antibodies reacting against Simian Virus 40 large T antigen mimotopes were detected in serum samples from elderly healthy subjects, up to 100 years old, with a prevalence of 22%. Immunological data were obtained with a novel indirect ELISA with synthetic peptides, which mimic the immunogenic epitopes of the viral oncoprotein of SV40. Our data suggests that the exposure to Simian Virus 40 infection is not frequent in old individuals. The immunological results showed that (i) the infection rate increases in elderly with the age; (ii) the proportion of elderly subjects with high Simian Virus 40 large T antigen antibody levels decreases with age; (iii) Simian Virus 40 infection spreads in old subjects independently from SV40‐contaminated vaccines; (iv) this monkey polyomavirus is also a viral agent in humans.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27064510</pmid><doi>10.1002/jcp.25405</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 2017-01, Vol.232 (1), p.176-181
issn 0021-9541
1097-4652
language eng
recordid cdi_proquest_miscellaneous_1827920403
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
Aging
Antibodies - blood
Antibodies - immunology
Antigens, Viral, Tumor - immunology
Female
Healthy Volunteers
Human populations
Humans
Immunization
Male
Oncogene Proteins - immunology
Peptides
Polyomaviridae
Polyomavirus
Polyomavirus Infections - immunology
Polyomavirus Infections - virology
Retroviridae
Seroepidemiologic Studies
Simian virus 40
Simian virus 40 - immunology
Tumor Virus Infections - immunology
Tumor Virus Infections - virology
Vaccines
title Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A01%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibodies%20Against%20Mimotopes%20of%20Simian%20Virus%2040%20Large%20T%20Antigen,%20the%20Oncoprotein,%20in%20Serum%20Samples%20From%20Elderly%20Healthy%20Subjects&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Mazzoni,%20Elisa&rft.date=2017-01&rft.volume=232&rft.issue=1&rft.spage=176&rft.epage=181&rft.pages=176-181&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.25405&rft_dat=%3Cproquest_pubme%3E1827920403%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1820870057&rft_id=info:pmid/27064510&rfr_iscdi=true